Tumor-Suppressor Inactivation of GDF11 Occurs by Precursor Sequestration in Triple-Negative Breast Cancer
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
SUMMARY Triple-negative breast cancer (TNBC) is an aggressive and heterogeneous carcinoma in which various tumor-suppressor genes are lost by mutation, deletion, or silencing. Here we report a tumor-suppressive mode of action for growth-differentiation factor 11 (GDF11) and an unusual mechanism of its inactivation in TNBC. GDF11 promotes an epithelial, anti-invasive phenotype in 3D triple-negative cultures and intraductal xenografts by sustaining expression of E-cadherin and inhibitor of differentiation 2 (ID2). Surprisingly, clinical TNBCs retain the GDF11 locus and expression of the protein itself. GDF11 bioactivity is instead lost because of deficiencies in its convertase, proprotein convertase subtilisin/kexin type 5 (PCSK5), causing inactive GDF11 precursor to accumulate intracellularly. PCSK5 reconstitution mobilizes the latent TNBC reservoir of GDF11 in vitro and suppresses triple-negative mammary cancer metastasis to the lung of syngeneic hosts. Intracellular GDF11 retention adds to the concept of tumor-suppressor inactivation and reveals a cell-biological vulnerability for TNBCs lacking therapeutically actionable mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Triple-negative breast cancer: clinical features and patterns of recurrence
Dent, R., Trudeau, M., Pritchard, K. I., Hanna, W. M., Kahn, H. K., Sawka, C. A., Lickley, L. A., Rawlinson, E., Sun, P., & Narod, S. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-3045 · Cited by 5,091 · cited 1×
“These so-called “triple-negative” breast cancers (TNBCs) are unlike other breast-cancer subtypes and have a very poor prognosis (Dent et al., 2007; Hoadley et al., 2014).”
BackgroundDiscovery and saturation analysis of cancer genes across 21 tumour types
Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096 · cited 1×
“For heavily sequenced cancers such as breast cancer (Lawrence et al., 2014), there are ripe opportunities to place somatic variants in the larger context of cancer cell biology.”
BackgroundPromoting an open research culture
Nosek, B. A., Alter, G., Banks, G. C., Borsboom, D., Bowman, S. D., Breckler, S. J., Buck, S., Chambers, C. D., Chin, G., Christensen, G., et al. (2015) · Science · doi:10.1126/science.aab2374 · Cited by 2,708 · cited 2×
“All terminal histology was preregistered with the Open Science Framework before beginning the tissue processing (https://osf.io/62cse/ and https://osf.io/ay2hu/).”
MethodThree-dimensional culture models of normal and malignant breast epithelial cells
Lee, G. Y., Kenny, P. A., Lee, E. H., & Bissell, M. J. (2007) · Nature Methods · doi:10.1038/nmeth1015 · Cited by 1,336
Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
Schafer, Z. T., Grassian, A. R., Song, L., Jiang, Z., Gerhart-Hines, Z., Irie, H. Y., Gao, S., Puigserver, P., & Brugge, J. S. (2009) · Nature · doi:10.1038/nature08268 · Cited by 1,031 · cited 1×
“During premalignancy, neoplastic cells hyperproliferate and enter the ductal lumen (Figure 7I, Step ii), experiencing severe detachment stress in search of basement membrane-type adhesions (Schafer et al., 2009; Wang et al., 2014).”
BackgroundLoffredo, F. S., Steinhauser, M. L., Jay, S. M., Gannon, J., Pancoast, J. R., Yalamanchi, P., Sinha, M., Dall’Osso, C., Khong, D., Shadrach, J. L., et al. (2013) · Cell · doi:10.1016/j.cell.2013.04.015 · Cited by 948 · cited 1×
“In our own animal work, activation of GDF11 signaling required intraductal co-inoculation, because we were unable to confirm bioavailability using established intraperitoneal regimens (Loffredo et al., 2013).”
MethodPulaski, B. A., & Ostrand‐Rosenberg, S. (2000) · Current Protocols in Immunology · doi:10.1002/0471142735.im2002s39 · Cited by 912
Three-dimensional organotypic culture: experimental models of mammalian biology and disease
Shamir, E. R., & Ewald, A. J. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3873 · Cited by 719 · cited 1×
“A tractable way to examine the cellular diversity of TNBCs and their precursors is through molecular analysis of three-dimensional (3D) cultures (Debnath and Brugge, 2005; Lee et al., 2007; Shamir and Ewald, 2014).”
BackgroundA public genome-scale lentiviral expression library of human ORFs
Yang, X., Boehm, J. S., Yang, X., Salehi-Ashtiani, K., Hao, T., Shen, Y., Lubonja, R., Thomas, S. R., Alkan, O., Bhimdi, T., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1638 · Cited by 570
GDF11 increases with age and inhibits skeletal muscle regeneration
Egerman, M. A., Cadena, S. M., Gilbert, J. A., Meyer, A., Nelson, H. N., Swalley, S. E., Mallozzi, C., Jacobi, C., Jennings, L. L., Clay, I., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.010 · Cited by 527 · cited 2×
“GDF11 protein expression was further verified with two different monoclonal antibodies: one that is specific for GDF11 (Figure 1B, green) and a second that localizes more cleanly to the Golgi but cross-reacts with GDF8/MSTN (Figure 1C, magenta, and Figure S1B), a ligand with 88% identity (Egerman et al., 2015).”
Background
Cited by
TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors
Edwards, A. C., Stalnecker, C. A., Jean Morales, A., Taylor, K. E., Klomp, J. E., Klomp, J. A., Waters, A. M., Sudhakar, N., Hallin, J., Tang, T. T., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-2994 · Cited by 91
Candidate rejuvenating factor GDF11 and tissue fibrosis: friend or foe?
Frohlich, J., & Vinciguerra, M. (2020) · GeroScience · doi:10.1007/s11357-020-00279-w · Cited by 28
Lin, T., Gu, J., Qu, K., Zhang, X., Ma, X., Miao, R., Xiang, X., Fu, Y., Niu, W., She, J., et al. (2018) · Aging · doi:10.18632/aging.101563 · Cited by 26
A methylation‐based mRNA signature predicts survival in patients with gastric cancer
Li, Y., Sun, R., Zhang, Y., Yuan, Y., & Miao, Y. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01374-w · Cited by 8
Proteome-wide copy-number estimation from transcriptomics
Sweatt, A. J., Griffiths, C. D., Groves, S. M., Paudel, B. B., Wang, L., Kashatus, D. F., & Janes, K. A. (2024) · Molecular Systems Biology · doi:10.1038/s44320-024-00064-3 · Cited by 5
Self-citation
Metadata
- Authors
- Bajikar, S. S., Wang, C.-C., Borten, M. A., Pereira, E. J., Atkins, K. A., & Janes, K. A.
- Venue
- Developmental Cell
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 43
- Issue
- 4
- Pages
- 418-435.e13
- ISSN
- 1534-5807 (ISSN-L)
- OpenAlex
- W2768491271
- Cited by
- 85
- References
- 18
- FWCI
- 2.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tumor-Suppressor Inactivation of GDF11 Occurs by Precursor Sequestration in Triple-Negative Breast Cancer. https://app.cochat.ai/papers/10.1016/j.devcel.2017.10.027
- The paper
- Bajikar, S. S., Wang, C.-C., Borten, M. A., Pereira, E. J., Atkins, K. A., & Janes, K. A. (2017). Tumor-Suppressor Inactivation of GDF11 Occurs by Precursor Sequestration in Triple-Negative Breast Cancer. Developmental Cell. https://doi.org/10.1016/j.devcel.2017.10.027
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.